We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ORGO market cap is 402.36M. The company's latest EPS is USD 0.0373 and P/E is 81.23.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 107.64M | 117.32M | 108.53M | 99.65M | 109.98M |
| Operating Income | -4M | 9.75M | 8.05M | -3.15M | -3.85M |
| Net Income | -2.97M | 5.32M | 3.17M | -568k | -2.1M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 260.98M | 338.3M | 468.06M | 450.89M | 433.14M |
| Operating Income | -29.46M | 27.42M | 72.92M | 22.3M | 12.53M |
| Net Income | -40.45M | 17.95M | 94.9M | 15.53M | 4.95M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 446.11M | 450.31M | 462.65M | 460.03M | 458.48M |
| Total Liabilities | 182.41M | 179.03M | 185.78M | 181.36M | 180.45M |
| Total Equity | 263.7M | 271.28M | 276.87M | 278.66M | 278.03M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 220.69M | 294.49M | 443.26M | 449.36M | 460.03M |
| Total Liabilities | 165.1M | 148.41M | 201.22M | 183.69M | 181.36M |
| Total Equity | 55.58M | 146.08M | 242.04M | 265.67M | 278.66M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.08M | 3.57M | 20.3M | 30.92M | -10.16M |
| Investing | -7.56M | -15.06M | -21.04M | -24.36M | -2.22M |
| Financing | -1.24M | -2.29M | -3.73M | -5.51M | -2.61M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -33.53M | 6.8M | 61.98M | 24.86M | 30.92M |
| Investing | -6.23M | -24.83M | -31.22M | -33.9M | -24.36M |
| Financing | 78.73M | 42.47M | -1.04M | -2.2M | -5.51M |
| Market Cap | 402.36M |
| Price to Earnings Ratio | 81.23 |
| Price to Sales Ratio | 0.93 |
| Price to Cash Ratio | 3.87 |
| Price to Book Ratio | 1.44 |
| Dividend Yield | - |
| Shares Outstanding | 132.57M |
| Average Volume (1 week) | 878.28k |
| Average Volume (1 Month) | 951.26k |
| 52 Week Change | -29.25% |
| 52 Week High | 4.705 |
| 52 Week Low | 1.96 |
| Spread (Intraday) | 0.01 (0.33%) |
| Company Name | Organogenesis Holdings Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://organogenesis.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
